Anamorelin
Also known as: ONO-7643, Adlumiz
Oral ghrelin receptor agonist; stimulates appetite, GH release, and lean mass retention. Non-peptide ghrelin mimetic.
- Typical dose
- 50 mg – 100 mg
- Frequency
- once daily
- Route
- Oral
- Half-life
- 7 hours
- Routes
- Oral
- Status
- Approved in Japan for cancer cachexia; not FDA-approved in US
Benefits
- Appetite stimulation
- Lean body mass increase
- GH elevation
- Anti-cachexia
Dosing
A common research range for Anamorelin is 50 mg to 100 mg once daily. Oral; 100mg daily on empty stomach. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Half-life
Anamorelin has an approximate half-life of 7 hours. Vial can display informational half-life estimates when supported data is available. These estimates are not measured blood concentrations or dosing instructions.
Storage
Room temperature.
Reported side effects
- Hyperglycemia
- Nausea
- Increased appetite
Contraindications
- Uncontrolled diabetes
- GI obstruction
Track Anamorelin with Vial
Vial logs every Anamorelin dose, organizes your schedule, and offers reconstitution math and supported half-life estimates. Tracking records stay on your device. A Vial Pro subscription is required. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. Anamorelin is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.